The American Diabetes Association’s (ADA) 83rd Scientific Sessions is almost here! From June 23-26, scientists and healthcare professionals will gather at one of the largest diabetes conference in the world. JDRF-funded researchers will also be there to present new study results that will improve outcomes for people with diabetes (T1D). Read what’s happening below.
ADA’s 83rd Scientific Sessions
- The Scientific Sessions is one of the largest gatherings of diabetes researchers in the world. Scientists and healthcare professionals share and learn about new diabetes conference advances with top experts.
- JDRF-supported research has been highlighted at this annual event since JDRF started funding research. This showcases new breakthroughs and therapies for people with T1D.
- This year, researchers will present 140+ studies—with JDRF-funding at present or in the past. This will encompass breakthrough clinical trials and significant research studies that are paving the way to novel treatments for T1D.
- JDRF-funded researchers will outline new advances such as:
- Cell Therapies
- How do we design a cell source—beyond stem cells—for future replacement approaches?
- Disease-Modifying Therapies
- What are the results of recent immunotherapy clinical trials?
- How do you stop the beta cells from being stressed out, furthering their destruction?
- Screening and Monitoring
- Global universal screening and monitoring: How far have we come and what’s next?
- How close are we to time-in-range being used for diabetes management?
- How do we create a world without visual loss from diabetes?
- Do-it-yourself (DIY) vs. commercial artificial pancreas systems: Which one is the best for you?
- Psychosocial Health
- What are the gaps in using telehealth for behavioral and psychological diabetes care?
Throughout the Scientific Sessions, JDRF will be sharing updates to keep people apprised of the day-to-day happenings:
- Blog posts before, during, and after the ADA meeting
- A Facebook Live event (@myJDRF) for each day, taking place the following day, with JDRF-funded scientists talking about the takeaways
- A “happy hour” with CEO Aaron J. Kowalski, Ph.D., from 7-8 p.m. ET on Thursday, June 29, speaking about the takeaways from the ADA Scientific Sessions and a Q&A period to answer questions from you, via Facebook Live (@myJDRF)
- Interviews with JDRF-funded scientists, who will go over their research and what it means to the T1D community, to be pushed out on social media
- To stay updated, follow us on Facebook (@myJDRF), Twitter (@JDRF), and LinkedIn, with the hashtags #JDRFxADA and #ADA2023